ScholarIQanswers from OpenAlex
Breast Cancer Research Foundation
InstitutionResearch output, impact & collaborations
Breast Cancer Research Foundation is a institution indexed in ScholarIQ from OpenAlex.
What is known about Breast Cancer Research Foundation?
ScholarIQrecord summary
Breast Cancer Research Foundation is a research organisation in New York, US. OpenAlex records 3,532 works and 705,612 citations for it. 1,149 researchers list it as their most recent affiliation.
How many works does Breast Cancer Research Foundation have?
ScholarIQindexed works
Breast Cancer Research Foundation has 3,532 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Breast Cancer Research Foundation have?
ScholarIQcitation count
Breast Cancer Research Foundation has 705,612 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Breast Cancer Research Foundation?
ScholarIQresearcher count
Breast Cancer Research Foundation has 1,149 researchers in the ScholarIQ index.
What is the average h-index at Breast Cancer Research Foundation?
ScholarIQavg h-index
Breast Cancer Research Foundation has an average h-index of 74.2 in OpenAlex.
What is the ROR of Breast Cancer Research Foundation?
ScholarIQror
The ROR for Breast Cancer Research Foundation is on the source record.
What is the OpenAlex record for Breast Cancer Research Foundation?
ScholarIQopenalex
The OpenAlex for Breast Cancer Research Foundation is on the source record.
What is the Wikidata of Breast Cancer Research Foundation?
ScholarIQwikidata
The Wikidata for Breast Cancer Research Foundation is on the source record.
Who are the most-cited researchers behind Breast Cancer Research Foundation?
ScholarIQtop researchers by citations
What are the most-cited papers on Breast Cancer Research Foundation?
ScholarIQmost cited works
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Shanu Modi, William Jacot, Toshinari Yamashita, Joohyuk Sohn, María Vidal, Eriko Tokunaga, Junji Tsurutani, Naoto T. Ueno, Aleix Prat, Yee Soo Chae, Keun Seok Lee, Naoki Niikura, Yeon Hee Park, Binghe Xu, Xiaojia Wang, Miguel Gil‐Gil, Wěi Li, Jean‐Yves Pierga, Seock‐Ah Im, Halle C. F. Moore, Hope S. Rugo, Rinat Yerushalmi, Flora Zagouri, Andrea Gombos, Sung‐Bae Kim, Qiang Liu, Ting Luo, Cristina Saura, Peter Schmid, Tao Sun, Dhiraj Gambhire, Lotus Yung, Yibin Wang, Jasmeet Singh, Patrik Vitazka, Gerold Meinhardt, Nadia Harbeck, David Cameron
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch–Shimon, Mario Campone, Kimberly Blackwell, Fabrice André, Eric P. Winer, Wolfgang Janni, Sunil Verma, PierFranco Conte, Carlos L. Arteaga, David Cameron, Katarína Petráková, Lowell L. Hart, Cristian Villanueva, Arlene Chan, Erik Jakobsen, Arnd Nusch, Olga Burdaeva, Eva‐Maria Grischke, Emilio Alba, Erik Wist, Norbert Marschner, Anne Favret, Denise A. Yardley, Thomas Bachelot, Ling-Ming Tseng, Sibel Blau, Fengjuan Xuan, Farida Souami, Michelle C. Miller, Caroline Germa, Samit Hirawat, Joyce O’Shaughnessy
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice André, Mónica Arnedos, Alexander S. Baras, José Baselga, Philippe L. Bédard, Michael F. Berger, Mariska Bierkens, Fabien Calvo, Ethan Cerami, Debyani Chakravarty, Kristen K. Dang, Nancy E. Davidson, Catherine Del Vecchio Fitz, Semih Doğan, Raymond N. DuBois, Matthew D. Ducar, P. Andrew Futreal, Jianjiong Gao, Francisco Moacir Pinheiro Garcia, Stuart M. Gardos, Christopher D. Gocke, Benjamin Groß, Justin Guinney, Zachary Heins, Stephanie Hintzen, Hugo M. Horlings, Jan Hudeček, David M. Hyman, Suzanne Kamel‐Reid, Cyriac Kandoth, Walter Kinyua, Priti Kumari, Ritika Kundra, Marc Ladanyi, Céline Lefèbvre, Michele L. Lenoue-Newton, Eva M. Lepisto, Mia Levy, Neal I. Lindeman, James Lindsay, David Liu, Zhibin Lu, Laura E. MacConaill, Ian Maurer, David S. Maxwell, Gerrit A. Meijer, Funda Meric‐Bernstam, Christine Micheel, Clinton Miller, Gordon B. Mills, Nathanael D. Moore, Petra M. Nederlof, Larsson Omberg, John A. Orechia, Ben Ho Park, Trevor J. Pugh, Brendan Reardon, Barrett J. Rollins, Mark J. Routbort, Charles L. Sawyers, Deborah Schrag, Nikolaus Schultz, Kenna Shaw, Priyanka Shivdasani, Lillian L. Siu, David B. Solit, Gabe S. Sonke, Jean Charles Soria, Parin Sripakdeevong, Natalie Stickle, Thomas Stricker, Shawn M. Sweeney, Barry S. Taylor, Jelle J. ten Hoeve, Stacy B. Thomas, Eliezer M. Van Allen, Laura van ‘t Veer, Tony van de Velde, Harm van Tinteren, Victor E. Velculescu, Carl Virtanen, Emile E. Voest, Lucy Lu Wang, Chetna Wathoo, Stuart Watt, Celeste Yu, Thomas Yu, Emily Yu, Ahmet Zehir, Hongxin Zhang
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens, Patrick Tarpey, Helen Davies, Peter Van Loo, Chris Greenman, David C. Wedge, Serena Nik‐Zainal, Sancha Martin, Ignacio Varela, Graham R. Bignell, Lucy Yates, Elli Papaemmanuil, David Beare, Adam Butler, Angela Cheverton, John Gamble, Jonathan Hinton, Mingming Jia, Alagu Jayakumar, David Jones, Calli Latimer, King Wai Lau, Stuart McLaren, David J. McBride, Andrew Menzies, Laura Mudie, Keiran Raine, Roland Rad, Michael Spencer Chapman, Jon W. Teague, Douglas F. Easton, Anita Langerød, Ming Ta Michael Lee, Chen‐Yang Shen, Benita Tan Kiat Tee, Bernice Wong Huimin, Annegien Broeks, Ana Cristina Vargas, Gulisa Turashvili, John W.M. Martens, Aquila Fatima, Penelope Miron, Suet‐Feung Chin, Gilles Thomas, Sandrine Boyault, Odette Mariani, Sunil R. Lakhani, Marc J. van de Vijver, Laura van ‘t Veer, John A. Foekens, Christine Desmedt, Christos Sotiriou, Andrew Tutt, Carlos Caldas, Jorge S. Reis‐Filho, Samuel Aparício, Anne Vincent‐Salomon, Anne‐Lise Børresen‐Dale, Andrea L. Richardson, Peter J. Campbell, P. Andrew Futreal, Michael R. Stratton
How much of the research on Breast Cancer Research Foundation is open access?
ScholarIQopen access share
100%OPEN ACCESS